<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="brief-report" dtd-version="2.3" xml:lang="EN">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Cell. Infect. Microbiol.</journal-id>
<journal-title>Frontiers in Cellular and Infection Microbiology</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Cell. Infect. Microbiol.</abbrev-journal-title>
<issn pub-type="epub">2235-2988</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3389/fcimb.2021.774899</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Cellular and Infection Microbiology</subject>
<subj-group>
<subject>Brief Research Report</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>HO-3867 Induces ROS-Dependent Stress Response and Apoptotic Cell Death in <italic>Leishmania donovani</italic>
</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Das</surname>
<given-names>Amrita</given-names>
</name>
<uri xlink:href="https://loop.frontiersin.org/people/1572946/overview"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Kamran</surname>
<given-names>Mohd.</given-names>
</name>
<uri xlink:href="https://loop.frontiersin.org/people/472894"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Ali</surname>
<given-names>Nahid</given-names>
</name>
<xref ref-type="author-notes" rid="fn001">
<sup>*</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/46086"/>
</contrib>
</contrib-group>
<aff id="aff1">
<institution>Infectious Diseases and Immunology Division, Council of Scientific and Industrial Research (CSIR)-Indian Institute of Chemical Biology</institution>, <addr-line>Kolkata</addr-line>, <country>India</country>
</aff>
<author-notes>
<fn fn-type="edited-by">
<p>Edited by: Arijit Bhattacharya, Adamas University, India</p>
</fn>
<fn fn-type="edited-by">
<p>Reviewed by: Danilo Ciccone Miguel, State University of Campinas, Brazil; Beatriz Simonsen Stolf, University of S&#xe3;o Paulo, Brazil</p>
</fn>
<fn fn-type="corresp" id="fn001">
<p>*Correspondence: Nahid Ali, <email xlink:href="mailto:nali@iicb.res.in">nali@iicb.res.in</email>, <email xlink:href="mailto:nahidali28@yahoo.in">nahidali28@yahoo.in</email>
</p>
</fn>
<fn fn-type="other" id="fn002">
<p>This article was submitted to Parasite and Host, a section of the journal Frontiers in Cellular and Infection Microbiology</p>
</fn>
</author-notes>
<pub-date pub-type="epub">
<day>03</day>
<month>12</month>
<year>2021</year>
</pub-date>
<pub-date pub-type="collection">
<year>2021</year>
</pub-date>
<volume>11</volume>
<elocation-id>774899</elocation-id>
<history>
<date date-type="received">
<day>13</day>
<month>09</month>
<year>2021</year>
</date>
<date date-type="accepted">
<day>12</day>
<month>11</month>
<year>2021</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#xa9; 2021 Das, Kamran and Ali</copyright-statement>
<copyright-year>2021</copyright-year>
<copyright-holder>Das, Kamran and Ali</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p>
</license>
</permissions>
<abstract>
<p>Lack of vaccine and increasing chemotherapeutic toxicities currently necessitate the development of effective and safe drugs against various forms of leishmaniases. We characterized the cellular stress induced by a novel curcumin analogue, HO-3867, encapsulated within the phosphatidylcholine-stearylamine (PC-SA) liposome for the first time against <italic>Leishmania</italic>. The liposomal formulation of HO-3867 (i.e., PC-SA/HO-3867) initiated oxidative stress-induced apoptosis in <italic>L. donovani</italic>, revealed by altered cell morphology, phosphatidylserine externalization, mitochondrial depolarization, intracellular lipid accumulation, and cell cycle arrest in promastigotes. Liposomal HO-3867 was observed to be a strong apoptosis inducer in <italic>L. donovani</italic> and <italic>L. major</italic> in a dose-dependent manner, yet completely safe for normal murine macrophages. Moreover, PC-SA/HO-3867 treatment induced <italic>L. donovani</italic> metacaspase and PARP1 activation along with downregulation of the Sir2 gene. PC-SA/HO-3867 arrested intracellular <italic>L. donovani</italic> amastigote burden <italic>in vitro</italic>, with reactive oxygen species (ROS) and nitric oxide (NO)-mediated parasite killing. These data suggest that liposomal HO-3867 represents a highly promising and non-toxic nanoparticle-based therapeutic platform against leishmaniasis inspiring further preclinical developments.</p>
</abstract>
<kwd-group>
<kwd>liposome</kwd>
<kwd>stress</kwd>
<kwd>
<italic>Leishmania donovani</italic>
</kwd>
<kwd>HO-3867</kwd>
<kwd>apoptosis</kwd>
</kwd-group>
<contract-sponsor id="cn001">Global Challenges Research Fund<named-content content-type="fundref-id">10.13039/100016270</named-content>
</contract-sponsor>
<contract-sponsor id="cn002">CSIR - Indian Institute of Chemical Biology<named-content content-type="fundref-id">10.13039/501100012323</named-content>
</contract-sponsor>
<counts>
<fig-count count="4"/>
<table-count count="0"/>
<equation-count count="2"/>
<ref-count count="46"/>
<page-count count="10"/>
<word-count count="5823"/>
</counts>
</article-meta>
</front>
<body>
<sec id="s1">
<title>Introduction</title>
<p>Visceral leishmaniasis (VL) or kala-azar is one of the deadly systemic infections caused by <italic>Leishmania donovani</italic>/<italic>Leishmania infantum</italic> with estimated 200,000&#x2013;400,000 new cases and more than 20,000&#x2013;30,000 deaths per year [<uri xlink:href="http://www.who.int/mediacentre/factsheets/fs375/en/">http://www.who.int/mediacentre/factsheets/fs375/en/</uri>]. Emergence of resistant parasites, drug-related toxicities, and HIV coinfection has further complicated the scenario of VL treatment in endemic regions (<xref ref-type="bibr" rid="B39">Singh et&#xa0;al., 2016</xref>; <xref ref-type="bibr" rid="B1">Alves et&#xa0;al., 2018</xref>). Thus, there is an unmet challenge to develop safe and alternative drugs to treat this fatal infection. HO-3867, a curcumin analogue belonging to class diarylidenylpiperidone (DAP), is a robust STAT3 inhibitor inducing reactive oxygen species (ROS), caspase-3, and PARP1-mediated apoptosis in cancer cells (<xref ref-type="bibr" rid="B35">Selvendiran et&#xa0;al., 2010</xref>; <xref ref-type="bibr" rid="B42">Tierney et&#xa0;al., 2012</xref>; <xref ref-type="bibr" rid="B31">Rath et&#xa0;al., 2014</xref>; <xref ref-type="bibr" rid="B24">Madan et&#xa0;al., 2018</xref>; <xref ref-type="bibr" rid="B25">Mast et&#xa0;al., 2019</xref>; <xref ref-type="bibr" rid="B22">Li et&#xa0;al., 2020</xref>). However, its potency has never been evaluated against any kinetoplastid parasites so far. Despite their multiple benefits, curcuminoids have limited clinical applications due to low bioavailability (<xref ref-type="bibr" rid="B27">Mohammed et&#xa0;al., 2004</xref>; <xref ref-type="bibr" rid="B3">Anand et&#xa0;al., 2007</xref>; <xref ref-type="bibr" rid="B40">Sinjari et&#xa0;al., 2019</xref>). PC-SA liposomes reportedly target surface exposed anionic phosphatidylserine (PS) abundant on majority of cancer cells (<xref ref-type="bibr" rid="B12">De et&#xa0;al., 2018</xref>) and <italic>Leishmania</italic> (<xref ref-type="bibr" rid="B4">Banerjee et&#xa0;al., 2008</xref>; <xref ref-type="bibr" rid="B44">Wanderley et&#xa0;al., 2020</xref>) owing to the direct interaction of this anionic membrane lipid with SA. Herein, we envisioned the potential targeting of <italic>Leishmania</italic> parasites by PC-SA liposomes encapsulating HO-3867 for effective therapy. The enhanced ROS accumulation in PC-SA/HO-3867-treated parasites leads to cell cycle arrest and concurrent depolarization of mitochondrial membrane potential (<xref ref-type="bibr" rid="B46">Zhao et&#xa0;al., 2004</xref>) possibly causing release of cytochrome c in the cytoplasm and DNA damage. This indicates involvement of the mitochondria-dependent intrinsic pathway (<xref ref-type="bibr" rid="B20">Kroemer et&#xa0;al., 2007</xref>) of cell death in <italic>L. donovani</italic> after PC-SA/HO-3867 incubation, which in turn activates metacaspase and PARP-1 as precursors of apoptosis. The results are further supported by ROS and NO-mediated inhibition of intracellular amastigote multiplication in murine peritoneal M&#x3a6; after treatment, which needs further <italic>in vivo</italic> evaluations.</p>
</sec>
<sec id="s2">
<title>Method</title>
<sec id="s2_1">
<title>Animals and Parasites</title>
<p>Healthy BALB/c mice bred at the animal house facility of the CSIR-Indian Institute of Chemical Biology [approved by the Committee for the purpose of Control and Supervision on Animal Experiments (CPCSEA), Govt. of India, and the Animal Ethics Committee (147/1999/CPSCEA) of CSIR-IICB] were used. <italic>L. donovani</italic> strain AG83 (ATCC<sup>&#xae;</sup> PRA413&#x2122;) were cultured at 22&#xb0;C in M199 (Sigma-Aldrich, St. Louis, MO) medium supplemented with 10% heat-inactivated FCS, 2 mM glutamine, penicillin (100 U/ml), and streptomycin (100 &#xb5;g/ml) (Sigma-Aldrich). Stationary-phase parasites are periodically subcultured to maintain an average density of 2 &#xd7; 10<sup>6</sup> cells/ml in M199 medium. <italic>L. major</italic> promastigotes strain 5ASKH (a kind gift from Dr. Subrata Adak, CSIR-IICB) were cultured at 26&#xb0;C in M199 medium with 10% heat-inactivated FCS, 200 &#xb5;M adenine, penicillin (100 U/ml), streptomycin (100 &#xb5;g/ml), and 40 mM HEPES (<xref ref-type="bibr" rid="B13">Dolai et&#xa0;al., 2008</xref>).</p>
</sec>
<sec id="s2_2">
<title>Preparation and Characterization of PC-SA/HO-3867 Liposomes</title>
<p>Cationic liposomes were prepared with 20 mg of phosphatidylcholine (PC) (Sigma-Aldrich) with stearylamine (SA) (Fluka) at a 7:2 molar ratio by thin-film rehydration method (<xref ref-type="bibr" rid="B12">De et&#xa0;al., 2018</xref>). For drug encapsulation, a methanolic solution of HO-3867 (Cayman Chemicals) (1 mg/ml) was added to the lipid film, dried overnight, and finally dispersed in 1 ml of 0.02 M PBS (pH = 7.4) to form a stock solution of 20 mg/ml with respect to PC. Rhodamine B (RhB)-labeled liposomes were prepared by adding 0.1 mg/ml of RhB (Sigma) in organic phase together with PC and SA followed by lipid film dispersion in 0.02 M PBS containing 5-carboxyfluorescein (0.1 mg/ml).</p>
<p>Particle sizes of PC-SA and PC-SA/HO-3867 were determined by DLS (dynamic light scattering) using Zetasizer Nano ZS (Malvern Instruments) as described previously (<xref ref-type="bibr" rid="B12">De&#xa0;et&#xa0;al., 2018</xref>). The morphology of liposomes was examined by atomic forced microscopy (AFM) following standard procedures after placing the sample on a freshly cleaved mica grid (<xref ref-type="bibr" rid="B11">Das et&#xa0;al., 2018</xref>).</p>
<p>Measurement of encapsulation efficiency was based on the absorbance at different concentrations of HO-3867 measured at 328 nm using a UV-visible spectrophotometer, calculated from the amount of free HO-3867 present in the unentrapped fraction after ultracentrifugation (100,000&#xd7; <italic>g</italic> for 1 h, at 4&#xb0;C) using the formula:</p>
<disp-formula>    <mml:math display="block" id="M1">
<mml:mrow>
<mml:mtext>Percent&#xa0;encapsulated&#x2009;</mml:mtext>
<mml:mo>=</mml:mo>
<mml:mfrac>
<mml:mrow>
<mml:mo stretchy="false">[</mml:mo>
<mml:mtext>Total&#x2009;HO</mml:mtext>
<mml:mo>&#x2212;</mml:mo>
<mml:mn>3867</mml:mn>
<mml:mo stretchy="false">]</mml:mo>
<mml:mo>&#x2212;</mml:mo>
<mml:mo stretchy="false">[</mml:mo>
<mml:mtext>Free&#x2009;HO</mml:mtext>
<mml:mo>&#x2212;</mml:mo>
<mml:mn>3867</mml:mn>
<mml:mo stretchy="false">]</mml:mo>
</mml:mrow>
<mml:mrow>
<mml:mtext>Total&#xa0;&#x2009;HO</mml:mtext>
<mml:mo>&#x2212;</mml:mo>
<mml:mn>3867</mml:mn>
</mml:mrow>
</mml:mfrac>
<mml:mo>&#xd7;</mml:mo>
<mml:mn>100</mml:mn>
<mml:mo>%</mml:mo>
</mml:mrow>
</mml:math>
</disp-formula>
</sec>
<sec id="s2_3">
<title>Cellular Uptake</title>
<p>Peritoneal macrophages (M&#x3a6;) isolated from na&#xef;ve BALB/c mice are cultured overnight on coverslips (18 mm<sup>2</sup>, 10<sup>6</sup> M&#x3a6;/coverslip) at 37&#xb0;C with 5% CO<sub>2</sub> in RPMI medium (Sigma-Aldrich) (<xref ref-type="bibr" rid="B11">Das et&#xa0;al., 2018</xref>). Resident M&#x3a6;s were infected with freshly transformed <italic>L. donovani</italic> promastigotes at a ratio of 1:10 for 4 h at 37&#xb0;C with 5% CO<sub>2</sub>. To assess the uptake efficacy and intracellular docking of free liposomes, infected and uninfected M&#x3a6; were treated with Rhodamine B (RhB) (red)-labeled PC-SA liposomes loaded with 5-carboxyfluorescein dye (green) for 2 h. The cells were next fixed with 4% paraformaldehyde (pH 7.4) and counterstained with DAPI (Invitrogen). The fluorescent signals were captured by a TCS-SP8 (Leica Microsystems, Germany) microscope equipped with Leica LAS X live cell imaging software. The lasers used were 405, 488, and 577 argon lasers for DAPI, 5-carboxyfluorescein, and RhB, respectively.</p>
</sec>
<sec id="s2_4">
<title>Promastigote and Amastigote Inhibitory Assays</title>
<p>To evaluate the effects of HO-3867 on promastigotes, 2 &#xd7; 10<sup>5</sup> parasites/ml were treated with graded concentrations of PC-SA liposomes and free and liposomal HO-3867 for 2 h, at 22&#xb0;C. The untreated and treated parasites were further incubated with 2 mg/ml of MTT [3,-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide] (Affymetrix) solution for 2 and 4 h at 37&#xb0;C as detailed previously (<xref ref-type="bibr" rid="B38">Shadab et&#xa0;al., 2017</xref>). The reduced formazan crystals were dissolved in DMSO, and absorbance was measured at 550 nm in a spectrophotometer.</p>
<p>For evaluating inhibitory effects of free and liposomal HO-3867 on intracellular amastigotes, RAW 264.7 cells (2 &#xd7; 10<sup>5</sup> cells/coverslip) were infected with log-phase promastigotes of <italic>L. donovani</italic> (in 1:10 ratio) for 4 h in RPMI 1640 medium supplemented with 10% FCS. Following the removal of free promastigotes by vigorous washing with 0.02 M PBS thrice, infected M&#x3a6;s were incubated without drug for an additional 24 h at 37&#xb0;C in 5% CO<sub>2</sub>. Next, the infected M&#x3a6;s were treated with free or liposomal HO-3867 (2, 5, 10, 30, 50, and 100 &#xb5;g/ml) diluted in fresh medium for 2 h. After the removal of liposomes and drug, the infected M&#x3a6;s were further kept for 72 h at 37&#xb0;C in a CO<sub>2</sub> incubator. After 72 h, the coverslips were washed with 0.02 M PBS and fixed with methanol (Merck) followed by Giemsa staining (1:20 dilution with deionized water, kept for 5&#x2013;10 min). The number of amastigotes was counted under light microscope for 200 M&#x3a6;s per sample and expressed as means of three independent experiments. The 50% inhibitory concentration (IC<sub>50</sub>) of free and liposomal drug was calculated for <italic>L. donovani</italic> promastigotes and intracellular amastigotes <italic>via</italic> a non-linear curve.</p>
</sec>
<sec id="s2_5">
<title>Determination of Cell Morphology</title>
<p>
<italic>L. donovani</italic> promastigotes treated with IC<sub>50</sub> concentration of free and liposomal HO-3867 and empty PC-SA liposomes for 2 h at 22&#xb0;C were harvested, washed in 0.02 M PBS, fixed in 4% paraformaldehyde on 18-mm<sup>2</sup> glass coverslips, and air dried. Cells were sometimes washed in 0.05 ml Milli-Q water to remove the salt depositions and air dried as mentioned. Contact mode AFM was done by PicoPlus 5500 AFM using a piezoscanner in a maximum range of 100 &#xb5;m and processed using PicoView 1.8 Advanced Software.</p>
</sec>
<sec id="s2_6">
<title>PS Exposure and TUNEL Assay</title>
<p>For Annexin-V binding, differently treated and untreated 1 &#xd7; 10<sup>6</sup> <italic>L. donovani</italic> promastigotes were suspended in 1 ml of 1&#xd7; Annexin-V binding buffer (BD Biosciences) and incubated for 5 min in the dark, at room temperature. Following addition of 4 &#xb5;l of propidium iodide (PI) (BD Biosciences), cells were analyzed by flow cytometry.</p>
<p>Terminal deoxyribonucleotidyl transferase (TdT)-mediated dUTP nick-end labeling (TUNEL) assay using an <italic>in-situ</italic> apoptosis detection kit (Takara) was performed to detect fragmented DNA in <italic>L. donovani</italic> promastigotes treated with or without liposomal HO-3867 for 2 h at 22&#xb0;C, according to the manufacturer&#x2019;s instructions. Briefly, 1 &#xd7; 10<sup>6</sup> cells were fixed in 4% paraformaldehyde (pH = 7.4) for 15 min and permeabilized using 100 &#xb5;l of permeabilization buffer for 5 min on ice. The cells were resuspended in 50 &#xb5;l of TUNEL labeling reaction mixture (TdT enzyme + labeling solution) and incubated in a dark-humidified chamber at 37&#xb0;C for 60 min. Cells treated only with 50 &#xb5;l of labeling solution (without enzyme) which served as negative control. The reaction was finally terminated by washing with 0.02 M PBS. The green fluorescence of apoptotic cells was analyzed by confocal microscopy at 488 nm.</p>
</sec>
<sec id="s2_7">
<title>Measurement of Mitochondrial Membrane Potential</title>
<p>Briefly, treated and untreated promastigotes (1 &#xd7; 10<sup>6</sup> cells) were resuspended in 500 &#xb5;l of 2 &#xb5;M JC-1 (Molecular Probes) and incubated for 15 min at 37&#xb0;C in the dark (<xref ref-type="bibr" rid="B12">De et&#xa0;al., 2018</xref>). Subsequently, the cells were washed in 0.02 M PBS and subjected to confocal microscopy following nuclear staining with Hoechst 33342 blue (Molecular Probes) for 5 min. The live cell confocal images were captured with 405 for Hoechst 33342, and 488 and 560 argon lasers for JC-1.</p>
</sec>
<sec id="s2_8">
<title>Caspase-Like Activity and ROS Estimation</title>
<p>
<italic>In-vivo</italic> caspase-like activity in <italic>L. donovani</italic> promastigotes was evaluated by flow cytometry using Intracellular Caspase Detection ApoStat Kit (R&amp; D systems) following the manufacturer&#x2019;s instructions. After liposomal HO-3867 exposure of promastigotes at 22&#xb0;C, cells were stained directly in culture medium for the last 30 min of treatment at 37&#xb0;C in a CO<sub>2</sub> incubator with 1 &#xb5;l ApoStat/100 &#xb5;l of cells. Cells were harvested, washed briefly in 0.02 M PBS and analyzed by flow cytometry using BD LSRFortessa.</p>
<p>Intracellular ROS (reactive oxygen species) generation after treatment of promastigotes with free and liposomal HO-3867 was measured using 10 &#xb5;M of green oxidant-sensitive dye 2&#x2032;,7&#x2032;-dichlorodihydrofluorescein diacetate (H<sub>2</sub>DCFDA, Molecular Probes) dye as reported earlier (<xref ref-type="bibr" rid="B38">Shadab et&#xa0;al., 2017</xref>; <xref ref-type="bibr" rid="B11">Das et&#xa0;al., 2018</xref>). After 30 min of incubation, cells were washed in 0.02 M PBS and finally analyzed by flow cytometry.</p>
</sec>
<sec id="s2_9">
<title>Quantification of Membrane Integrity and Lipid Accumulation</title>
<p>
<italic>L. donovani</italic> promastigotes harvested with or without treatment were stained with 10 &#xb5;g/ml Nile Red (Sigma-Aldrich) for 30 min followed by following nuclear staining with Hoechst 33342 blue (Molecular Probes) for 5 min. Confocal live cell images were captured with 405 for Hoechst 33342, and 470 (for non-polar/neutral lipids) and 546 (for polar lipids) argon lasers for Nile Red (<xref ref-type="bibr" rid="B33">Rosa et&#xa0;al., 2015</xref>).</p>
</sec>
<sec id="s2_10">
<title>Real-Time PCR</title>
<p>Real-time PCR analysis for <italic>L. donovani</italic> metacaspase, PARP-1 genes, and SIR2 genes was done with gene-specific primers (<xref ref-type="bibr" rid="B30">Purkait et&#xa0;al., 2012</xref>; <xref ref-type="bibr" rid="B38">Shadab et&#xa0;al., 2017</xref>). Primers for amplifying metacaspase, Sir2, and PARP1 cDNAs were as follows: LdMetacaspase forward, 5&#x2032; AAA CGG GTC GAC ATT AAT GC 3&#x2032; and LdMetacaspase reverse 5&#x2032; CGA GCA TGA GGA AAA GAT CA3&#x2032;, LdSir2 forward, 5&#x2032; GGTCATCATCATCGGGACAT 3&#x2032; and LdSir2 reverse 5&#x2032; TCATCAGGAA AGCGGAAGAG 3&#x2032;, LdPARP1 forward, 5&#x2032; TGCCGGAAGGCGGCTCATTC 3&#x2032; and LdPARP1 reverse, 5&#x2032; CGCAGTGCGTTGCGCATACC 3&#x2032;, GAPDH forward, 5&#x2032; GAAGTACACGGTGGAGGCTG 3&#x2032;, GAPDH reverse, 5&#x2032;CGCTGATCACGACCTTCTTC 3&#x2032;. <italic>L. donovani</italic> cDNAs were amplified using SYBR Green Real-Time Master Mix (Roche). Gene expression levels were determined from Cq values followed by normalization of values of each gene (<xref ref-type="bibr" rid="B23">Livak and Schmittgen, 2001</xref>; <xref ref-type="bibr" rid="B34">Schmittgen and Livak, 2008</xref>) with expression levels of GAPDH by 2<sup>-&#x394;&#x394;</sup>
<italic>
<sup>Ct</sup>
</italic>. The fold expression was calculated as:</p>
<disp-formula>
<mml:math display="block" id="M2">
<mml:mrow>
<mml:mtext>Fold expression&#xa0;</mml:mtext>
<mml:mo>=</mml:mo>
<mml:mtext>&#xa0;</mml:mtext>
<mml:msup>
<mml:mn>2</mml:mn>
<mml:mo>&#x2212;</mml:mo>
</mml:msup>
<mml:mrow>
<mml:mtext>&#x394;&#x394;</mml:mtext>
<mml:mi>C</mml:mi>
<mml:mi>t</mml:mi>
</mml:mrow>
</mml:mrow>
</mml:math>
</disp-formula>
</sec>
<sec id="s2_11">
<title>DNA Fragmentation and Cell Cycle Analysis in <italic>L. donovani</italic>
</title>
<p>
<italic>L. donovani</italic> promastigotes were treated with 10 &#xb5;g/ml of free and liposomal HO-3867 or empty PC-SA liposomes for 2 h, and genomic DNA was isolated using the Suicide Track &#x2122; DNA Ladder Isolation Kit (Calbiochem) using the manufacturer&#x2019;s instructions (<xref ref-type="bibr" rid="B38">Shadab et&#xa0;al., 2017</xref>). After washing in 70% ethanol, the genomic DNA pellets obtained were finally dispersed in resuspension buffer (10 Mm Tris&#x2013;HCl, pH = 7.5, 1 Mm EDTA) and visualized with 0.5 &#xb5;g/ml ethidium bromide (EtBr) staining, under a Bio-Rad Gel Documentation system.</p>
<p>For cell cycle analysis, after for 2 and 6 h of drug treatment, <italic>L.&#xa0;donovani</italic> promastigotes were harvested, washed in 0.02 M PBS, and fixed in 70% ethanol (constituted in PBS) overnight. Cells were stained with FxCycle&#x2122; PI/RNase Staining Solution (Molecular Probes) for 30 min at room temperature. The percentage of cells in different cell cycle phases, i.e., G0, G0/G1, S, and G2/M, was gated using BD LSRFortessa and analyzed by BD FACS Scan Software.</p>
</sec>
<sec id="s2_12">
<title>Evaluation of <italic>In Vitro</italic> Macrophage (M&#x3a6;) Infection</title>
<p>Peritoneal M&#x3a6;s collected from na&#xef;ve BALB/c mice were plated overnight in RPMI 1640 medium on 18-mm<sup>2</sup> glass coverslips as detailed previously (<xref ref-type="bibr" rid="B11">Das et&#xa0;al., 2018</xref>). M&#x3a6;s were infected <italic>in vitro</italic> with <italic>L. donovani</italic> promastigotes at a 1:10 ratio for 4 h at 37&#xb0;C in a CO<sub>2</sub> incubator. After removing free promastigotes by three successive washings with 0.02 M PBS, infected M&#x3a6;s were incubated without drug for 24 h at 37&#xb0;C in 5% CO<sub>2</sub>. Next, the infected M&#x3a6;s were treated with free or liposomal HO-3867 (10 &#xb5;g/ml) diluted in fresh medium for 2 h. Excess liposomes and drug were removed after 2 h, and the infected M&#x3a6;s were kept for an additional 48 and 72 h at 37&#xb0;C in a CO<sub>2</sub> incubator. Finally, the coverslips were washed with 0.02 M PBS and fixed with methanol (Merck) followed by Giemsa staining. The number of amastigotes was counted under a light microscope for 200 M&#x3a6;s per sample and expressed as means of three independent experiments. Nitric oxide (NO) production was quantified in culture supernatants of HO-3867 and PC-SA/HO-3867 (10 &#xb5;g/ml) treated M&#x3a6;s by Griess Reagent (absorbance 540 nm) (<xref ref-type="bibr" rid="B11">Das et&#xa0;al., 2018</xref>). ROS generation in the infected M&#x3a6;s was assessed by 10 &#xb5;M H<sub>2</sub>DCFDA using a Synergy H1 (Biotek) microplate reader (excitation/emission = 485 nm/528 nm) (<xref ref-type="bibr" rid="B11">Das et&#xa0;al., 2018</xref>).</p>
</sec>
<sec id="s2_13">
<title>Statistical Analysis</title>
<p>GraphPad prism version 6.0 (GraphPad Software) was used for statistical analyses. One-way analysis of variance (ANOVA) and Tukey&#x2013;Kramer multiple-comparison test were used for comparing between groups. <italic>p</italic> &lt; 0.05 was considered as statistically significant difference for all the experiments.</p>
</sec>
</sec>
<sec id="s3">
<title>Results and Discussion</title>
<sec id="s3_1">
<title>Characterization of PC-SA/HO-3867</title>
<p>HO-3867-entrapped PC-SA liposomes were developed by thin-film rehydration method (<xref ref-type="bibr" rid="B12">De et&#xa0;al., 2018</xref>). Stearylamine (SA) was incorporated to impart high <italic>Leishmania</italic> targeting ability of these cationic liposomes (<xref ref-type="bibr" rid="B4">Banerjee et&#xa0;al., 2008</xref>). The mean particle size, zeta potential, and drug encapsulation efficacy of PC-SA/HO-3867 were 164 &#xb1; 15 nm, 46 &#xb1; 8.5 mV, and 88.4 &#xb1; 5.2%, respectively. The morphology of PC-SA/HO-3867 liposomes as characterized by AFM at 150&#x2013;300 kHz frequency (<xref ref-type="bibr" rid="B46">Zhao et&#xa0;al., 2004</xref>) depicted their smooth spherical structures without visible aggregation (<xref ref-type="fig" rid="f1">
<bold>Figures&#xa0;1A, B</bold>
</xref>).</p>
<fig id="f1" position="float">
<label>Figure&#xa0;1</label>
<caption>
<p>Vesicle morphology and effect of liposomal HO-3867 on <italic>L. donovani</italic> promastigotes 2 h post-treatment. <bold>(A)</bold> Tapping mode AFM images of PC-SA/HO-3867 liposomes. Topography is indicative of the height of the liposomes from the mica base. <bold>(B)</bold> Representative three-dimensional AFM image of PC-SA/HO-3867 liposomes. <bold>(C)</bold> Effect of increasing concentrations of empty liposomes and free and liposomal HO-3867 on viability of log-phase promastigotes estimated by MTT assay. Inset depicts the morphological alterations of control, empty PC-SA liposomes (10 &#xb5;g/ml w.r.t PC), and drug-treated promastigotes under a phase-contrast microscope. <bold>(D)</bold> Nile Red (NR)-fluorescent quantification of polar (orange-red) and non-polar (yellowish green) lipid accumulation in promastigotes with or without free and liposomal HO-3867 treatment. <bold>(E)</bold> Representative bar diagram showing the ratio of polar/non-polar (i.e., red/green) lipids in differently treated promastigotes. <bold>(F)</bold> DNA fragmentation in promastigotes treated with IC<sub>50</sub> dose of PC-SA/HO-3867, free HO-3867, and PC-SA liposomes. Lane 1, GeneRuler 50-bp DNA ladder (Thermo); Lanes 2&#x2013;5, untreated, promastigotes treated with 10 &#xb5;g/ml of free HO-3867, PC-SA liposomes, and liposomal HO-3867, respectively. <bold>(G)</bold> Intracellular ROS generation in log-phase promastigotes after treatment with free and liposomal HO-3867, by H<sub>2</sub>DCFDA. <bold>(H)</bold> Bar graph showing means of caspase-positive cells in differently treated and untreated parasites, in absence or presence of pan-caspase inhibitor z-VAD-fmk, as analyzed by flow cytometry. Each data represent mean &#xb1; S.E. (n = 3) and is one of the three experiments with similar results. *<italic>p</italic> &lt; 0.05; **<italic>p</italic> &lt; 0.001; ***<italic>p &lt; </italic>0.0001, as assessed by one-way ANOVA and Tukey&#x2019;s multiple-comparison test.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fcimb-11-774899-g001.tif"/>
</fig>
</sec>
<sec id="s3_2">
<title>PC-SA/HO-3867 Induced Cell-Death in <italic>L. donovani</italic> Is Chiefly ROS-Mediated</title>
<p>MTT (Invitrogen) colorimetric assay reveals the significant dose-dependent cytotoxicity of free and liposomal HO-3867 (1&#x2013;200 &#xb5;g/ml) against promastigotes (<xref ref-type="fig" rid="f1">
<bold>Figure&#xa0;1C</bold>
</xref>) and intracellular amastigotes (<xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Table&#xa0;1</bold>
</xref>) of <italic>L. donovani</italic> without affecting normal mammalian cells, even after treatment with 100 &#xb5;g/ml of PC-SA/HO-3867 (equivalent to PC-SA/HO-3867 containing 215.26 &#xb5;M of HO-3867 in liposomes). IC<sub>50</sub> values of free HO-3867 against <italic>L. donovani</italic> and <italic>L. major</italic> were 30 and 33.5 &#xb5;g/ml, respectively. Much lower IC<sub>50</sub> values of 10 and 12.5 &#xb5;g/ml were obtained after exposure to PC-SA/HO-3867 in <italic>L. donovani</italic> and <italic>L. major</italic>, respectively.</p>
<p>Accumulation of excess cellular lipid has long been associated with stress-induced apoptosis (<xref ref-type="bibr" rid="B9">Boren and Brindle, 2012</xref>; <xref ref-type="bibr" rid="B33">Rosa et&#xa0;al., 2015</xref>). To address the changes in the ratio of polar and non-polar lipids after treatment, lipophilic marker Nile Red (0.1 &#xb5;g/ml) was used, which shows the characteristic shift from red to green emission in the presence of polar and non-polar lipids, respectively (<xref ref-type="bibr" rid="B16">Greenspan et&#xa0;al., 1985</xref>; <xref ref-type="bibr" rid="B33">Rosa et&#xa0;al., 2015</xref>). Intense yellowish green (neutral) fluorescent lipid droplets are seen to be accumulated in drug-treated promastigotes compared to prominent orange red punctuations (polar) of membrane lipids seen in control (<xref ref-type="fig" rid="f1">
<bold>Figure&#xa0;1D</bold>
</xref>). Also, quantitative analysis of whole cells (ex 514 &#xb1; 20/em 550 &#xb1; 40 for non-polar or neutral lipids; ex 560 &#xb1; 20/em 620 &#xb1; 50 for polar lipids) revealed significant accumulation of neutral lipids in drug-treated parasites over controls. The red/green ratio changed from 2.2 &#xb1; 0.1 in controls to 1.6 &#xb1; 0.14 in HO-3867 and 1.4 &#xb1; 0.12 in PC-SA/HO-3867-treated parasites, confirming the accumulation of non-polar/neutral lipids after 2 h (<xref ref-type="fig" rid="f1">
<bold>Figure&#xa0;1E</bold>
</xref>). Similar to earlier reports (<xref ref-type="bibr" rid="B18">Kathuria et&#xa0;al., 2014</xref>; <xref ref-type="bibr" rid="B15">Garcia et&#xa0;al., 2017</xref>), our study shows leishmanicidal activity of HO-3867 with surplus accumulation neutral lipid bodies in the cytoplasm indicating faulty lipid metabolism. We also performed DNA laddering assay (<xref ref-type="fig" rid="f1">
<bold>Figure&#xa0;1F</bold>
</xref>), which shows marked genomic DNA fragmentation in HO-3867, PC-SA, and HO-3867/PC-SA-treated <italic>L. donovani</italic> promastigotes compared to untreated controls (showing no such oligonucleosome-sized fragments).</p>
<p>Although sublethal ROS production sustains cellular homeostasis, a drastic ROS upsurge is associated with apoptosis (<xref ref-type="bibr" rid="B5">Basmaciyan et&#xa0;al., 2018</xref>). Fluorescent labeling of cells with H<sub>2</sub>DCFDA showed an almost fourfold increase in intracellular ROS (<xref ref-type="fig" rid="f1">
<bold>Figure&#xa0;1G</bold>
</xref>) in promastigotes compared to free drugs indicative of imbalanced cellular redox homeostasis and programmed cell death (PCD) in parasites after 2 h. As a key regulator of PCD, the presence of caspase-like proteases was evaluated in untreated and treated <italic>L. donovani</italic> promastigotes (<xref ref-type="bibr" rid="B38">Shadab et&#xa0;al., 2017</xref>). A significantly high caspase-like activity of empty PC-SA liposomes and PC-SA/HO-3867 was observed compared to free HO-3867 (<xref ref-type="fig" rid="f1">
<bold>Figure&#xa0;1H</bold>
</xref>). To confirm the assay specificity, promastigotes were preincubated for 1 h with z-VAD-fmk, a pan-caspase inhibitor, followed by PC-SA/HO-3867 treatment which showed significant reduction (<italic>p</italic> &lt; 0.01) in absorbance. Increased caspase-like activity in promastigotes by PC-SA/HO-3867 treatment is possibly due to PC-SA liposomes, a known activator of caspase-mediated cell death (<xref ref-type="bibr" rid="B12">De et&#xa0;al., 2018</xref>). We also observed involvement of caspase-independent cell death in free HO-3867-treated <italic>L. donovani</italic> promastigotes but caspase-mediated apoptosis after PC-SA and PC-SA/HO-3867 treatment. This is probably due to the synergistic antileishmanial activity of PC-SA liposomes and HO-3867.</p>
</sec>
<sec id="s3_3">
<title>PC-SA/HO3867 Causes Altered Cell Morphology, DNA Fragmentation, and Cell Cycle Arrest in Promastigotes</title>    <p>Marked cytoskeletal alterations like rounded cell shrinkage, decrease in flagellar length, or loss of flagella is frequently reported during PCD in <italic>Leishmania</italic> (<xref ref-type="bibr" rid="B2">Ambit et&#xa0;al., 2011</xref>). AFM studies revealed that both free and liposomal HO-3867-treated parasites exhibited cell shrinkage after 2 h, with maximum cytoplasmic condensation with PC-SA/HO3867 treatment (<xref ref-type="fig" rid="f2">
<bold>Figures&#xa0;2A, B</bold>
</xref>). Compared to the typical smooth, elongated shape of normal promastigotes, PC-SA/HO3867 treatment resulted in irregular cell morphology, membrane blebbing, and flagellar distortion (<xref ref-type="fig" rid="f2">
<bold>Figures&#xa0;2A&#x2013;C</bold>
</xref>) in <italic>L. donovani</italic>. Similar morphological changes have earlier been associated with apoptosis-like cell death in <italic>L. donovani</italic> by clerodane diterpene (<xref ref-type="bibr" rid="B18">Kathuria et&#xa0;al., 2014</xref>) and Kalsome (<xref ref-type="bibr" rid="B38">Shadab et&#xa0;al., 2017</xref>) and curcumin in <italic>L. infantum</italic> (<xref ref-type="bibr" rid="B14">Eaton et&#xa0;al., 2014</xref>).</p>
<fig id="f2" position="float">
<label>Figure&#xa0;2</label>
<caption>
<p>AFM images comparing the effects of free and liposomal HO-3867 upon log-phase promastigotes of <italic>L. donovani</italic> at half-maximal inhibitory concentration (IC<sub>50</sub>: 10 &#xb5;g/ml or 21.5 &#x3bc;M). <bold>(A)</bold> Two-dimensional images of control, HO-3867, empty PC-SA liposomes, and PC-SA/HO-3867-treated promastigotes. Surface smoothness and height are indicated by histograms for control, liposomes, and free and liposomal HO-3867-treated promastigotes in the lower panel. <bold>(B)</bold> Mean body length/breadth ratio of differently treated promastigotes. Data are mean &#xb1; S.E. (n = 3) derived from one of the three independent experiments (***<italic>p &lt; </italic>0.001), calculated by one-way ANOVA and Tukey&#x2019;s multiple-comparison test. <bold>(C)</bold> Representative 3D images of HO-3867, empty liposomes, and PC-SA/HO-3867-treated promastigotes after 2 h. <bold>(D)</bold> Confocal images showing genomic DNA fragmentation in controls and liposomal HO-3867-treated promastigotes, using TUNEL staining. Intact nuclei are visualized in blue (DAPI), and TUNEL-positive nuclei are stained green (FITC). The data represent one of the three experiments with similar results. **<italic>p</italic> &lt; 0.01.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fcimb-11-774899-g002.tif"/>
</fig>
<p>Fragmentation of nuclear DNA is an essential hallmark of apoptosis in eukaryotes. Quantification of nuclear DNA nicking in PC-SA/HO-3867-treated parasites was determined by TUNEL assay based on binding of terminal deoxynucleotidyl transferase (TdT) enzyme to the 3&#x2032;-OH end of the fragmented DNA. Hence, the FITC-fluorescence obtained is directly proportional to the fragmented DNA inside cells. Promastigotes treated with 10 &#xb5;g/ml of liposomal HO-3867 for 2 h showed increased DNA nicking as evidenced from enhanced green fluorescence compared to the untreated controls, observed under a confocal microscope (<xref ref-type="fig" rid="f2">
<bold>Figure&#xa0;2D</bold>
</xref>).</p>
<p>Targeting the cell proliferation <italic>in vitro</italic> can provide mechanistic insight into novel antileishmanial drugs. The effect of liposomal and free HO-3867 on cell cycle progression was examined by flow cytometry by staining the permeabilized cells with PI. PC-SA/HO-3867 induced a significant increase (~3.4-fold) in the subG0 cell cycle compared to the untreated controls after 2 and 6 h (<xref ref-type="fig" rid="f3">
<bold>Figures&#xa0;3A, B</bold>
</xref>). After 2 h, the percentage of cells in the subG0 phase was around 8% in the untreated promastigotes, which increased to 20% and 26%, in the <italic>L. donovani</italic> promastigotes treated with free and liposomal HO-3867, respectively. These data clearly demonstrate the growth-inhibitory effect of free and liposomal HO-3867 on <italic>L. donovani</italic>, with cell cycle arrest in the subG0 phase, observed till 6 h post-treatment.</p>
<fig id="f3" position="float">
<label>Figure&#xa0;3</label>
<caption>
<p>Analysis of cell cycle arrest and mechanism of cell death in free and liposomal HO-3867-treated <italic>L. donovani</italic> promastigotes. <bold>(A)</bold> Cell cycle distribution of log-phase parasites after treatment with or without liposomal HO-3867 for 2 and 6 h. <bold>(B)</bold> Statistical analysis of subG0 accumulation in cell cycle distribution measured by flow cytometry after free drug and PC-SA/HO-3867 treatment. <bold>(C)</bold> Representative flow cytometry dot plots showing promastigotes left untreated or treated with 10 &#xb5;g/ml of free or PC-SA liposome-entrapped HO-3867 for 2 h were stained with Annexin V-FITC and PI. <bold>(D)</bold> Early (Annexin V<sup>+</sup>PI<sup>-</sup>) and late apoptosis (Annexin V<sup>+</sup>PI<sup>+</sup>) of promastigotes after Annexin V-FITC/PI staining following treatment with 10 &#xb5;g/ml of free drug or PC-SA/HO-3867. <bold>(E)</bold> Fold change of <italic>L. donovani</italic> metacaspase (LdMC), LdPARP1, and LdSir2 genes relative to internal GAPDH control in drug-treated parasites compared to controls. Data (mean &#xb1; S.E.) are one of the three independent experiments. *<italic>p &lt; </italic>0.05, **<italic>p &lt; </italic>0.001, ***<italic>p &lt; </italic>0.0001 compared to saline control, assessed by one-way ANOVA and Tukey&#x2019;s multiple-comparison test.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fcimb-11-774899-g003.tif"/>
</fig>
</sec>
<sec id="s3_4">
<title>PC-SA/HO-3867 Induces PS-Externalization and <italic>L. donovani</italic> Metacaspase and PARP1 Overexpression</title>
<p>Cellular death has been broadly categorized into apoptotic and necrotic pathways. Apoptotic cell death in unicellular protozoan parasites is almost always associated with translocation of PS from the inner to outer leaflet of the cell membrane (<xref ref-type="bibr" rid="B28">Nikoletopoulou et&#xa0;al., 2013</xref>). Flow cytometry analysis based on Annexin V-FITC/PI dual staining was used to differentiate between apoptotic cells after treatment. Our results showed late apoptosis (Annexin V<sup>+</sup>PI<sup>+</sup>) in nearly 30% of PC-SA/HO-3867-treated cells compared to only 8.5% and 6.2% cells in free HO-3867-treated and controls, respectively (<xref ref-type="fig" rid="f3">
<bold>Figures&#xa0;3C, D</bold>
</xref>), without any increase in necrotic population (Annexin V<sup>-</sup>PI<sup>+</sup>). The results strongly indicate that liposomal HO-3867 treatment resulted in apoptosis of <italic>L. donovani</italic> largely due to increased externalization of some anionic membrane lipids like phosphatidylglycerol, phosphatidylethanolamine, and phosphatidic acid, along with a small amount of PS in the promastigote outer membrane binding Annexin V (<xref ref-type="bibr" rid="B17">Imbert et&#xa0;al., 2012</xref>; <xref ref-type="bibr" rid="B45">Weing&#xe4;rtner et&#xa0;al., 2012</xref>). Although <italic>Leishmania</italic> promastigotes possess less outer-membrane PS compared to amastigotes (<xref ref-type="bibr" rid="B10">Bouazizi-Ben Messaoud et&#xa0;al., 2017</xref>), this little amount of PS along with other anionic membrane lipids on <italic>Leishmania</italic> promastigotes seems to be adequate for interacting with cationic PC-SA liposomes for successful targeting of the parasites.</p>
<p>The viability and virulence of <italic>Leishmania</italic> parasites depend upon some key enzymes like metacaspase and PARP-1 (poly[ADP]-ribose polymerase-1) genes, compared to SIR2 (silent information regulator)-related proteins (<xref ref-type="bibr" rid="B36">Sengupta et&#xa0;al., 2011</xref>; <xref ref-type="bibr" rid="B26">Mittal et&#xa0;al., 2017</xref>; <xref ref-type="bibr" rid="B6">Basmaciyan and Casanova, 2019</xref>). Stress-induced overexpression of PARP1 can lead to suppression of sirtuins (SIR2) <italic>via</italic> depletion of intracellular nicotine adenine dinucleotide (NAD) levels resulting in ATP depletion, DNA damage, and cell death in protozoan parasites (<xref ref-type="bibr" rid="B26">Mittal et&#xa0;al., 2017</xref>). Real-time PCR analysis with gene-specific primers and <italic>L. donovani</italic> GAPDH (<xref ref-type="bibr" rid="B30">Purkait et&#xa0;al., 2012</xref>; <xref ref-type="bibr" rid="B38">Shadab et&#xa0;al., 2017</xref>) showed a 3.5- and 1.6-fold increase of <italic>L. donovani</italic> metacaspase and PARP1 respectively in liposomal HO-3867-treated parasites over free drugs (<xref ref-type="fig" rid="f3">
<bold>Figure&#xa0;3E</bold>
</xref>). Also, an almost 1.5-fold reduction in SIR2 gene expression was observed in PC-SA/HO-3867-treated parasites compared to free drugs, after 6 h. Thus, liposomal HO-3867-mediated parasite killing is associated with overexpression of <italic>L. donovani</italic> metacaspase, PARP1 with concomitant downregulation of SIR2 in promastigotes.</p>
</sec>
<sec id="s3_5">
<title>PC-SA/HO-3867 Causes Depolarization of Mitochondrial Membrane</title>
<p>Mitochondria are vital cell organelles for proper cellular function and viability. Disruption of mitochondrial integrity and loss of mitochondrial membrane potential are striking features of apoptosis (<xref ref-type="bibr" rid="B21">Lee et&#xa0;al., 2002</xref>; <xref ref-type="bibr" rid="B20">Kroemer et&#xa0;al., 2007</xref>). Changes in mitochondrial membrane potential in treated cells were measured by confocal microscopy and flow cytometry gating using the MitoProbe JC-1 Assay Kit (<xref ref-type="bibr" rid="B32">Reers et&#xa0;al., 1995</xref>; <xref ref-type="bibr" rid="B38">Shadab et&#xa0;al., 2017</xref>; <xref ref-type="bibr" rid="B41">Sivandzade et&#xa0;al., 2019</xref>). As shown in <xref ref-type="fig" rid="f4">
<bold>Figures&#xa0;4A&#x2013;C</bold>
</xref>, the aggregated JC-1 (red) is released from parasite mitochondria to the cytoplasm as monomers (green) following treatment with free and liposomal HO-3867 (10 &#xb5;g/ml), indicating significant mitochondrial damage after 2 h. However, in controls, intense JC-1 red fluorescence is indicative of healthy mitochondria (<xref ref-type="fig" rid="f4">
<bold>Figure&#xa0;4A</bold>
</xref>). The relative mitochondrial depolarization (red/green JC-1 ratio) (<xref ref-type="fig" rid="f4">
<bold>Figure&#xa0;4C</bold>
</xref>) showed 9.5-fold lower red/green ratios in liposomal HO-3867-treated promastigotes compared to untreated controls (<xref ref-type="fig" rid="f4">
<bold>Figure&#xa0;4C</bold>
</xref>).</p>
<fig id="f4" position="float">
<label>Figure&#xa0;4</label>
<caption>
<p>
<italic>In vitro</italic> leishmanicidal effect of liposomal HO-3867. <bold>(A&#x2013;C)</bold> <italic>In situ</italic> mitochondrial membrane potential of promastigotes after a 2-h treatment with or without liposomal HO-3867, as estimated by JC-1 staining. An almost complete JC-1 monomer was induced by 50 &#xb5;M CCCP, uncoupling mitochondrial respiration, taken as positive control. Confocal images <bold>(A)</bold>, flow cytometry dot plot <bold>(B)</bold>, and the bar graph <bold>(C)</bold> intensity of red/green JC-1 ratio. <bold>(D)</bold> Internalization of fluorescent PC-SA liposomes (membrane stained with red RhB encapsulating the green 5-carboxyfluorescein stain inside core) inside the uninfected (i and <italic>in vitro L. donovani</italic>-infected (ii) peritoneal M&#x3a6; from healthy BALB/c mice. Intact PC-SA liposomes (yellow) are seen near macrophage nuclei (blue). White arrows indicate intracellular <italic>L.&#xa0;donovani</italic> amastigotes (small blue dots). Magnification, &#xd7;40. Data are representative of three independent experiments with similar results. <bold>(E)</bold> Intracellular parasite burden in peritoneal M&#x3a6; from na&#xef;ve BALB/c mice infected with promastigotes treated with HO-3867 (10 &#xb5;g/ml), PC-SA/HO-3867, and empty PC-SA liposomes (10 &#xb5;g/ml w.r.t PC) for 48 and 72 h post infection, expressed as number of amastigotes/100 M&#x3a6;s in the form of bar graph. NO <bold>(F)</bold> and ROS <bold>(G)</bold> production by the treated M&#x3a6; after 48 and 72 h in response to <italic>in vitro</italic> infection. Data (mean &#xb1; S.E.) are derived from the three independent experiments with similar results. *<italic>p &lt; </italic>0.05, **<italic>p &lt; </italic>0.001, ***<italic>p &lt; </italic>0.0001 compared to saline control as assessed by one-way ANOVA and Tukey&#x2019;s multiple-comparison test.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fcimb-11-774899-g004.tif"/>
</fig>
</sec>
<sec id="s3_6">
<title>Internalization of PC-SA Liposomes by <italic>L. donovani</italic>-Infected M&#x3a6;</title>
<p>Macrophage (M&#x3a6;)-targeted drug delivery has been of specific interest in leishmaniasis due to the versatility of macrophages to act as host cells as well as central APCs in the processing of liposomal antigens (<xref ref-type="bibr" rid="B19">Kelly et&#xa0;al., 2011</xref>; <xref ref-type="bibr" rid="B7">Bogdan, 2020</xref>). A profound effect of particle size on its efficacy and biodistribution has been reported, with medium-sized liposomes of size ~150&#x2013;200 nm having the longest circulation time and better efficacy (<xref ref-type="bibr" rid="B37">Sercombe et&#xa0;al., 2015</xref>; <xref ref-type="bibr" rid="B7">Bogdan, 2020</xref>). Confocal microscopic analysis of intracellular fates of PC-SA liposomes was carried out by labeling the vesicles with Rhodamine B (red) entrapping 5-carboxyfluorescein dye (green) (<xref ref-type="bibr" rid="B11">Das et&#xa0;al., 2018</xref>). Although no initial difference in uptake between infected and non-infected M&#x3a6; was observed after 10 min (data not shown) of incubation, more accumulation of intact PC-SA liposomes (yellow) was seen inside infected M&#x3a6; (nuclei labeled with DAPI) close to intracellular amastigotes (small blue dots) (<xref ref-type="fig" rid="f4">
<bold>Figure&#xa0;4D</bold>
</xref>, i and ii) compared to non-infected cells after a brief incubation time of 2 h. Interestingly, in accordance with some previous studies (<xref ref-type="bibr" rid="B37">Sercombe et&#xa0;al., 2015</xref>; <xref ref-type="bibr" rid="B7">Bogdan, 2020</xref>), the fluorescent PC-SA liposomes (<xref ref-type="fig" rid="f4">
<bold>Figure&#xa0;4D</bold>
</xref>) were seen to be preferentially internalized by the <italic>L. donovani</italic>-infected M&#x3a6;s compared to uninfected M&#x3a6;, ensuring better antileishmanial effect of the drug <italic>in vivo</italic>. This is possibly due to altered phagocytosis by parasitized APCs (<xref ref-type="bibr" rid="B29">Noronha et&#xa0;al., 2000</xref>; <xref ref-type="bibr" rid="B8">Borborema et&#xa0;al., 2011</xref>). This suggests that PC-SA liposomes more effectively target parasitized M&#x3a6;s than the non-infected ones, thereby increasing the efficacy of the drug.</p>
</sec>
<sec id="s3_7">
<title>PC-SA/HO-3867 Activates NO and ROS Mediated Killing of <italic>L. donovani</italic> Amastigotes</title>
<p>M&#x3a6;s are the main phagocytic cells playing a dual role in <italic>Leishmania</italic> infection acting as chief host cells sustaining amastigote multiplication as well as helping in parasite clearance (<xref ref-type="bibr" rid="B43">Tomiotto-Pellissier et&#xa0;al., 2018</xref>). To investigate whether the antileishmanial effect of PC-SA/HO-3867 observed in <italic>L. donovani</italic> promastigotes extended to intracellular amastigotes, <italic>in vitro</italic> infected murine peritoneal M&#x3a6;s were treated with an IC<sub>50</sub> concentration of free and PC-SA/HO-3867 (10 &#xb5;g/ml) for 48 and 72 h. As shown in <xref ref-type="fig" rid="f4">
<bold>Figure&#xa0;4E</bold>
</xref>, a significantly higher time-dependent suppression of intracellular amastigote multiplication was noted upon PC-SA/HO-3867 treatment compared to controls and free HO-3867 at 48 h (<italic>p</italic> &lt; 0.001) and 72 h (<italic>p</italic> &lt; 0.0001) post-treatment in peritoneal M&#x3a6;s. We further investigated the amount of secreted NO and ROS in culture supernatants of infected and drug-treated M&#x3a6;s after 48 and 72 h. Compared to free HO-3867, PC-SA/HO-3867 treatment induced 1.5- and 2.6-fold higher NO (<xref ref-type="fig" rid="f4">
<bold>Figure&#xa0;4E</bold>
</xref>) and ROS (<xref ref-type="fig" rid="f4">
<bold>Figure&#xa0;4F</bold>
</xref>) generation, respectively (<italic>p</italic> &lt; 0.0001), after 72 h. One plausible explanation for this enhanced efficacy of liposomal HO-3867 is the synergistic leishmanicidal effect of cationic PC-SA liposomes with HO-3867 in a synergistic manner. Collectively, our results emphasize the antileishmanial potency of liposomal HO-3867 as a strong and safe drug candidate for VL, which merit future preclinical evaluation.</p>
</sec>
</sec>
<sec id="s4" sec-type="data-availability">
<title>Data Availability Statement</title>    <p>The original contributions presented in the study are included in the article/<xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Material</bold>
</xref>. Further inquiries can be directed to the corresponding author.</p>
</sec>
<sec id="s5" sec-type="ethics-statement">
<title>Ethics Statement</title>
<p>The animal study was reviewed and approved by the Committee for the purpose of Control and Supervision on Animal Experiments (CPCSEA), Govt. of India, and Animal Ethics Committee (147/1999/CPSCEA) of CSIR-IICB.</p>
</sec>
<sec id="s6" sec-type="author-contributions">
<title>Author Contributions</title>
<p>AD and MK performed experiments. AD and NA equally contributed to perception and intellectual conceptualization of the work. All authors contributed to the article and approved the submitted version.</p>
</sec>
<sec id="s7" sec-type="funding-information">
<title>Funding</title>
<p>NA is a fellow of J.C. Bose National Fellowship, which provided financial support. This work was financially supported by the Council of Scientific and Industrial Research (CSIR) grant (No. BSC0114) and UK Research and Innovation grant &#x201c;A global Network for Neglected Tropical Diseases&#x201d; (No. MR/P027989/1). J.C. Bose National Fellowship also for financial support, as Dr. Ali is a J.C. Bose National Fellow.</p>
</sec>
<sec id="s8" sec-type="COI-statement">
<title>Conflict of Interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
<sec id="s9" sec-type="disclaimer">
<title>Publisher&#x2019;s Note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
</body>
<back>
<ack>
<title>Acknowledgments</title>
<p>AD is a CSIR Research Associate. The authors thank Dr. Arun Bandopadhyay, the Director, CSIR-IICB, India, for supporting this work.</p>
</ack>
<sec id="s10" sec-type="supplementary-material">
<title>Supplementary Material</title>
<p>The Supplementary Material for this article can be found online at: <ext-link ext-link-type="uri" xlink:href="https://www.frontiersin.org/articles/10.3389/fcimb.2021.774899/full#supplementary-material">https://www.frontiersin.org/articles/10.3389/fcimb.2021.774899/full#supplementary-material</ext-link></p>
<supplementary-material xlink:href="DataSheet_1.doc" id="SM1" mimetype="application/msword"/>
</sec>
<ref-list>
<title>References</title>
<ref id="B1">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Alves</surname> <given-names>F.</given-names>
</name>
<name>
<surname>Bilbe</surname> <given-names>G.</given-names>
</name>
<name>
<surname>Blesson</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Goyal</surname> <given-names>V.</given-names>
</name>
<name>
<surname>Monnerat</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Mowbray</surname> <given-names>C.</given-names>
</name>
<etal/>
</person-group>. (<year>2018</year>). <article-title>Recent Development of Visceral Leishmaniasis Treatments: Successes, Pitfalls, and Perspectives</article-title>. <source>Clin. Microbiol. Rev.</source> <volume>31</volume>, <fpage>e00048</fpage>&#x2013;<lpage>e00018</lpage>. doi: <pub-id pub-id-type="doi">10.1128/CMR.00048-18</pub-id>
</citation>
</ref>
<ref id="B2">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ambit</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Woods</surname> <given-names>K. L.</given-names>
</name>
<name>
<surname>Cull</surname> <given-names>B.</given-names>
</name>
<name>
<surname>Coombs</surname> <given-names>G. H.</given-names>
</name>
<name>
<surname>Mottram</surname> <given-names>J. C.</given-names>
</name>
</person-group> (<year>2011</year>). <article-title>Morphological Events During the Cell Cycle of <italic>Leishmania Major</italic>
</article-title>. <source>Eukaryot. Cell.</source> <volume>10</volume>, <fpage>1429</fpage>&#x2013;<lpage>1438</lpage>. doi: <pub-id pub-id-type="doi">10.1128/EC.05118-11</pub-id>
</citation>
</ref>
<ref id="B3">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Anand</surname> <given-names>P.</given-names>
</name>
<name>
<surname>Kunnumakkara</surname> <given-names>A. B.</given-names>
</name>
<name>
<surname>Newman</surname> <given-names>R. A.</given-names>
</name>
<name>
<surname>Aggarwal</surname> <given-names>B. B.</given-names>
</name>
</person-group> (<year>2007</year>). <article-title>Bioavailability of Curcumin: Problems and Promises</article-title>. <source>Mol. Pharm.</source> <volume>4</volume>, <fpage>807</fpage>&#x2013;<lpage>818</lpage>. doi: <pub-id pub-id-type="doi">10.1021/mp700113r</pub-id>
</citation>
</ref>
<ref id="B4">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Banerjee</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Roychoudhury</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Ali</surname> <given-names>N.</given-names>
</name>
</person-group> (<year>2008</year>). <article-title>Stearylamine-Bearing Cationic Liposomes Kill <italic>Leishmania</italic> Parasites Through Surface Exposed Negatively Charged Phosphatidylserine</article-title>. <source>J. Antimicrob. Chemother.</source> <volume>61</volume>, <fpage>103</fpage>&#x2013;<lpage>110</lpage>. doi: <pub-id pub-id-type="doi">10.1093/jac/dkm396</pub-id>
</citation>
</ref>
<ref id="B5">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Basmaciyan</surname> <given-names>L.</given-names>
</name>
<name>
<surname>Azas</surname> <given-names>N.</given-names>
</name>
<name>
<surname>Casanova</surname> <given-names>M.</given-names>
</name>
</person-group> (<year>2018</year>). <article-title>Different Apoptosis Pathways in <italic>Leishmania</italic> Parasites</article-title>. <source>Cell Death Discov.</source> <volume>4</volume>, <fpage>27</fpage>. doi: <pub-id pub-id-type="doi">10.1038/s41420-018-0092-z</pub-id>
</citation>
</ref>
<ref id="B6">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Basmaciyan</surname> <given-names>L.</given-names>
</name>
<name>
<surname>Casanova</surname> <given-names>M.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>Cell Death in <italic>Leishmania</italic>
</article-title>. <source>Parasite</source> <volume>26</volume>, <fpage>71</fpage>. doi: <pub-id pub-id-type="doi">10.1051/parasite/2019071</pub-id>
</citation>
</ref>
<ref id="B7">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bogdan</surname> <given-names>C.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>Macrophages as Host, Effector and Immunoregulatory Cells in Leishmaniasis: Impact of Tissue Micro-Environment and Metabolism</article-title>. <source>Cytokine X</source> <volume>2</volume>, <fpage>100041</fpage>. doi: <pub-id pub-id-type="doi">10.1016/j.cytox.2020.100041</pub-id>
</citation>
</ref>
<ref id="B8">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Borborema</surname> <given-names>S. E.</given-names>
</name>
<name>
<surname>Schwendener</surname> <given-names>R. A.</given-names>
</name>
<name>
<surname>Osso</surname> <given-names>J. A.</given-names> <suffix>Jr</suffix>
</name>
<name>
<surname>de Andrade</surname> <given-names>H. F.</given-names> <suffix>Jr</suffix>
</name>
<name>
<surname>do Nascimento</surname> <given-names>N.</given-names>
</name>
</person-group> (<year>2011</year>). <article-title>Uptake and Antileishmanial Activity of Meglumine Antimoniate-Containing Liposomes in <italic>Leishmania (Leishmania) Major-</italic>Infected Macrophages</article-title>. <source>Int. J. Antimicrob. Agents</source> <volume>38</volume>, <fpage>341</fpage>&#x2013;<lpage>347</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.ijantimicag.2011.05.012</pub-id>
</citation>
</ref>
<ref id="B9">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Boren</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Brindle</surname> <given-names>K. M.</given-names>
</name>
</person-group> (<year>2012</year>). <article-title>Apoptosis-Induced Mitochondrial Dysfunction Causes Cytoplasmic Lipid Droplet Formation</article-title>. <source>Cell Death Differ.</source> <volume>19</volume>, <fpage>1561</fpage>&#x2013;<lpage>1570</lpage>. doi: <pub-id pub-id-type="doi">10.1038/cdd.2012.34</pub-id>
</citation>
</ref>
<ref id="B10">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bouazizi-Ben Messaoud</surname> <given-names>H.</given-names>
</name>
<name>
<surname>Guichard</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Lawton</surname> <given-names>P.</given-names>
</name>
<name>
<surname>Delton</surname> <given-names>I.</given-names>
</name>
<name>
<surname>Azzouz-Maache</surname> <given-names>S.</given-names>
</name>
</person-group> (<year>2017</year>). <article-title>Changes in Lipid and Fatty Acid Composition During Intramacrophagic Transformation of <italic>Leishmania Donovani</italic> Complex Promastigotes Into Amastigotes</article-title>. <source>Lipids</source> <volume>52</volume> (<issue>5</issue>), <fpage>433</fpage>&#x2013;<lpage>441</lpage>. doi: <pub-id pub-id-type="doi">10.1007/s11745-017-4233-6</pub-id>
</citation>
</ref>
<ref id="B11">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Das</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Asad</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Sabur</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Didwania</surname> <given-names>N.</given-names>
</name>
<name>
<surname>Ali</surname> <given-names>N.</given-names>
</name>
</person-group> (<year>2018</year>). <article-title>Monophosphoryl Lipid A Based Cationic Liposome Facilitates Vaccine Induced Expansion of Polyfunctional T Cell Immune Responses Against Visceral Leishmaniasis</article-title>. <source>ACS Appl. Bio Mater.</source> <volume>1</volume>, <fpage>999</fpage>&#x2013;<lpage>1018</lpage>. doi: <pub-id pub-id-type="doi">10.1021/acsabm.8b00184</pub-id>
</citation>
</ref>
<ref id="B12">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>De</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Ghosh</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Sen</surname> <given-names>T.</given-names>
</name>
<name>
<surname>Shadab</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Banerjee</surname> <given-names>I.</given-names>
</name>
<name>
<surname>Basu</surname> <given-names>S.</given-names>
</name>
<etal/>
</person-group>. (<year>2018</year>). <article-title>A Novel Therapeutic Strategy for Cancer Using Phosphatidylserine Targeting Stearylamine-Bearing Cationic Liposomes</article-title>. <source>Mol. Ther. Nucleic Acids</source> <volume>10</volume>, <fpage>9</fpage>&#x2013;<lpage>27</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.omtn.2017.10.019</pub-id>
</citation>
</ref>
<ref id="B13">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dolai</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Yadav</surname> <given-names>R. K.</given-names>
</name>
<name>
<surname>Pal</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Adak</surname> <given-names>S.</given-names>
</name>
</person-group> (<year>2008</year>). <article-title>
<italic>Leishmania Major</italic> Ascorbate Peroxidase Overexpression Protects Cells Against Reactive Oxygen Species-Mediated Cardiolipin Oxidation</article-title>. <source>Free Radic. Biol. Med.</source> <volume>45</volume>, <fpage>1520</fpage>&#x2013;<lpage>1529</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.freeradbiomed.2008.08.029</pub-id>
</citation>
</ref>
<ref id="B14">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Eaton</surname> <given-names>P.</given-names>
</name>
<name>
<surname>Bittencourt</surname> <given-names>C. R.</given-names>
</name>
<name>
<surname>Costa Silva</surname> <given-names>V.</given-names>
</name>
<name>
<surname>V&#xe9;ras</surname> <given-names>L. M.</given-names>
</name>
<name>
<surname>Costa</surname> <given-names>C. H.</given-names>
</name>
<name>
<surname>Feio</surname> <given-names>M. J.</given-names>
</name>
<etal/>
</person-group>. (<year>2014</year>). <article-title>Anti-Leishmanial Activity of the Antimicrobial Peptide DRS 01 Observed in <italic>Leishmania Infantum</italic> (Syn. <italic>Leishmania Chagasi</italic>) Cells</article-title>. <source>Nanomedicine</source> <volume>10</volume>, <fpage>483</fpage>&#x2013;<lpage>490</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.nano.2013.09.003</pub-id>
</citation>
</ref>
<ref id="B15">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Garcia</surname> <given-names>F. P.</given-names>
</name>
<name>
<surname>Henrique da Silva Rodrigues</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Din</surname> <given-names>Z. U.</given-names>
</name>
<name>
<surname>Rodrigues-Filho</surname> <given-names>E.</given-names>
</name>
<name>
<surname>Ueda-Nakamura</surname> <given-names>T.</given-names>
</name>
<name>
<surname>Auz&#xe9;ly-Velty</surname> <given-names>R.</given-names>
</name>
<etal/>
</person-group>. (<year>2017</year>). <article-title>A3K2A3-Induced Apoptotic Celldeath of <italic>Leishmania Amazonensis</italic> Occurs Through Caspase- and ATP-Dependent Mitochondrial Dysfunction</article-title>. <source>Apoptosis</source> <volume>22</volume>, <fpage>57</fpage>&#x2013;<lpage>71</lpage>. doi: <pub-id pub-id-type="doi">10.1007/s10495-016-1308-4</pub-id>
</citation>
</ref>
<ref id="B16">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Greenspan</surname> <given-names>P.</given-names>
</name>
<name>
<surname>Mayer</surname> <given-names>E. P.</given-names>
</name>
<name>
<surname>Fowler</surname> <given-names>S. D.</given-names>
</name>
</person-group> (<year>1985</year>). <article-title>Nile Red: A Selective Fluorescent Stain for Intracellular Lipid Droplets</article-title>. <source>J. Cell Biol.</source> <volume>100</volume>, <fpage>965</fpage>&#x2013;<lpage>973</lpage>. doi: <pub-id pub-id-type="doi">10.1083/jcb.100.3.965</pub-id>
</citation>
</ref>
<ref id="B17">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Imbert</surname> <given-names>L.</given-names>
</name>
<name>
<surname>Ramos</surname> <given-names>R. G.</given-names>
</name>
<name>
<surname>Libong</surname> <given-names>D.</given-names>
</name>
<name>
<surname>Abreu</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Loiseau</surname> <given-names>P. M.</given-names>
</name>
<name>
<surname>Chaminade</surname> <given-names>P.</given-names>
</name>
</person-group> (<year>2012</year>). <article-title>Identification of Phospholipid Species Affected by Miltefosine Action in <italic>Leishmania Donovani</italic> Cultures Using LC-ELSD, LC-ESI/MS, and Multivariate Data Analysis</article-title>. <source>Anal. Bioanal. Chem.</source> <volume>402</volume>, <fpage>1169</fpage>&#x2013;<lpage>1182</lpage>. doi: <pub-id pub-id-type="doi">10.1007/s00216-011-5520-3</pub-id>
</citation>
</ref>
<ref id="B18">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kathuria</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Bhattacharjee</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Sashidhara</surname> <given-names>K. V.</given-names>
</name>
<name>
<surname>Singh</surname> <given-names>S. P.</given-names>
</name>
<name>
<surname>Mitra</surname> <given-names>K.</given-names>
</name>
</person-group> (<year>2014</year>). <article-title>Induction of Mitochondrialdysfunction and Oxidative Stress in <italic>Leishmania Donovani</italic> by Orally Active Clerodane Diterpene</article-title>. <source>Antimicrob. Agents Chemother.</source> <volume>58</volume>, <fpage>5916</fpage>&#x2013;<lpage>5928</lpage>. doi: <pub-id pub-id-type="doi">10.1128/AAC.02459-14</pub-id>
</citation>
</ref>
<ref id="B19">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kelly</surname> <given-names>C.</given-names>
</name>
<name>
<surname>Jefferies</surname> <given-names>C.</given-names>
</name>
<name>
<surname>Cryan</surname> <given-names>S. A.</given-names>
</name>
</person-group> (<year>2011</year>). <article-title>Targeted Liposomal Drug Delivery to Monocytes and Macrophages</article-title>. <source>J. Drug Deliv.</source> <volume>2011</volume>, <fpage>727241</fpage>. doi: <pub-id pub-id-type="doi">10.1155/2011/727241</pub-id>
</citation>
</ref>
<ref id="B20">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kroemer</surname> <given-names>G.</given-names>
</name>
<name>
<surname>Galluzzi</surname> <given-names>L.</given-names>
</name>
<name>
<surname>Brenner</surname> <given-names>C.</given-names>
</name>
</person-group> (<year>2007</year>). <article-title>Mitochondrial Membrane Permeabilization in Cell Death</article-title>. <source>Physiol. Rev.</source> <volume>87</volume>, <fpage>99</fpage>&#x2013;<lpage>163</lpage>. doi: <pub-id pub-id-type="doi">10.1152/physrev.00013.2006</pub-id>
</citation>
</ref>
<ref id="B21">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lee</surname> <given-names>N.</given-names>
</name>
<name>
<surname>Bertholet</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Debrabant</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Muller</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Duncan</surname> <given-names>R.</given-names>
</name>
<name>
<surname>Nakhasi</surname> <given-names>H. L.</given-names>
</name>
</person-group> (<year>2002</year>). <article-title>Programmed Cell Death in the Unicellular Protozoan Parasite <italic>Leishmania</italic>
</article-title>. <source>Cell Death Differ.</source> <volume>9</volume>, <fpage>53</fpage>&#x2013;<lpage>64</lpage>. doi: <pub-id pub-id-type="doi">10.1038/sj.cdd.4400952</pub-id>
</citation>
</ref>
<ref id="B22">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname> <given-names>Z.</given-names>
</name>
<name>
<surname>Shi</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Li</surname> <given-names>N.</given-names>
</name>
<name>
<surname>Xu</surname> <given-names>R.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>Application of Functional Biocompatible Nanomaterials to Improve Curcumin Bioavailability</article-title>. <source>Front. Chem.</source> <volume>8</volume>, <elocation-id>589957</elocation-id>. doi: <pub-id pub-id-type="doi">10.3389/fchem.2020.589957</pub-id>
</citation>
</ref>
<ref id="B23">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Livak</surname> <given-names>K. J.</given-names>
</name>
<name>
<surname>Schmittgen</surname> <given-names>T. D.</given-names>
</name>
</person-group> (<year>2001</year>). <article-title>Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2(-Delta Delta C(T)) Method</article-title>. <source>Methods</source> <volume>25</volume>, <fpage>402</fpage>&#x2013;<lpage>408</lpage>. doi: <pub-id pub-id-type="doi">10.1006/meth.2001.1262</pub-id>
</citation>
</ref>
<ref id="B24">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Madan</surname> <given-names>E.</given-names>
</name>
<name>
<surname>Parker</surname> <given-names>T. M.</given-names>
</name>
<name>
<surname>Bauer</surname> <given-names>M. R.</given-names>
</name>
<name>
<surname>Dhiman</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Pelham</surname> <given-names>C. J.</given-names>
</name>
<name>
<surname>Nagane</surname> <given-names>M.</given-names>
</name>
<etal/>
</person-group>. (<year>2018</year>). <article-title>The Curcumin Analog HO-3867 Selectively Kills Cancer Cells by Converting Mutant P53 Protein to Transcriptionally Active Wildtype P53</article-title>. <source>J. Biol. Chem.</source> <volume>293</volume>, <fpage>4262</fpage>&#x2013;<lpage>4276</lpage>. doi: <pub-id pub-id-type="doi">10.1074/jbc.RA117.000950</pub-id>
</citation>
</ref>
<ref id="B25">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mast</surname> <given-names>J. M.</given-names>
</name>
<name>
<surname>Tse</surname> <given-names>D.</given-names>
</name>
<name>
<surname>Shee</surname> <given-names>K.</given-names>
</name>
<name>
<surname>Lakshmi Kuppusamy</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Kmiec</surname> <given-names>M. M.</given-names>
</name>
<name>
<surname>K&#xe1;lai</surname> <given-names>T.</given-names>
</name>
<etal/>
</person-group>. (<year>2019</year>). <article-title>Diarylidenylpiperidones, H-4073 and HO-3867, Induce G2/M Cell-Cycle Arrest, Apoptosis and Inhibit STAT3 Phosphorylation in Human Pancreatic Cancer Cells</article-title>. <source>Cell Biochem. Biophys.</source> <volume>77</volume>, <fpage>109</fpage>&#x2013;<lpage>119</lpage>. doi: <pub-id pub-id-type="doi">10.1007/s12013-019-00873-6</pub-id>
</citation>
</ref>
<ref id="B26">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mittal</surname> <given-names>N.</given-names>
</name>
<name>
<surname>Muthuswami</surname> <given-names>R.</given-names>
</name>
<name>
<surname>Madhubala</surname> <given-names>R.</given-names>
</name>
</person-group> (<year>2017</year>). <article-title>The Mitochondrial SIR2 Related Protein 2 (SIR2RP2) Impacts <italic>Leishmania Donovani</italic> Growth and Infectivity</article-title>. <source>PloS Negl. Trop. Dis.</source> <volume>11</volume> (<issue>5</issue>), <fpage>e0005590</fpage>. doi: <pub-id pub-id-type="doi">10.1371/journal.pntd.0005590</pub-id>
</citation>
</ref>
<ref id="B27">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mohammed</surname> <given-names>A. R.</given-names>
</name>
<name>
<surname>Weston</surname> <given-names>N.</given-names>
</name>
<name>
<surname>Coombes</surname> <given-names>A. G.</given-names>
</name>
<name>
<surname>Fitzgerald</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Perrie</surname> <given-names>Y.</given-names>
</name>
</person-group> (<year>2004</year>). <article-title>Liposome Formulation of Poorly Water Soluble Drugs: Optimisation of Drug Loading and ESEM Analysis of Stability</article-title>. <source>Int. J. Pharm.</source> <volume>285</volume>, <fpage>23</fpage>&#x2013;<lpage>34</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.ijpharm.2004.07.010</pub-id>
</citation>
</ref>
<ref id="B28">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nikoletopoulou</surname> <given-names>V.</given-names>
</name>
<name>
<surname>Markaki</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Palikaras</surname> <given-names>K.</given-names>
</name>
<name>
<surname>Tavernarakis</surname> <given-names>N.</given-names>
</name>
</person-group> (<year>2013</year>). <article-title>Crosstalk Between Apoptosis, Necrosis and Autophagy</article-title>. <source>Biochim. Biophys. Acta</source> <volume>1833</volume>, <fpage>3448</fpage>&#x2013;<lpage>3459</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.bbamcr.2013.06.001</pub-id>
</citation>
</ref>
<ref id="B29">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Noronha</surname> <given-names>F. S.</given-names>
</name>
<name>
<surname>Cruz</surname> <given-names>J. S.</given-names>
</name>
<name>
<surname>Beir&#xe3;o</surname> <given-names>P. S.</given-names>
</name>
<name>
<surname>Horta</surname> <given-names>M. F.</given-names>
</name>
</person-group> (<year>2000</year>). <article-title>Macrophage Damage by <italic>Leishmania Amazonensis</italic> Cytolysin: Evidence of Pore Formation on Cell Membrane</article-title>. <source>Infect. Immun.</source> <volume>68</volume>, <fpage>4578</fpage>&#x2013;<lpage>4584</lpage>. doi: <pub-id pub-id-type="doi">10.1128/IAI.68.8.4578-4584.2000</pub-id>
</citation>
</ref>
<ref id="B30">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Purkait</surname> <given-names>B.</given-names>
</name>
<name>
<surname>Kumar</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Nandi</surname> <given-names>N.</given-names>
</name>
<name>
<surname>Sardar</surname> <given-names>A. H.</given-names>
</name>
<name>
<surname>Das</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Kumar</surname> <given-names>S.</given-names>
</name>
<etal/>
</person-group>. (<year>2012</year>). <article-title>Mechanism of Amphotericin B Resistance in Clinical Isolates of <italic>Leishmania Donovani</italic>
</article-title>. <source>Antimicrob. Agents Chemother.</source> <volume>56</volume>, <fpage>1031</fpage>&#x2013;<lpage>1041</lpage>. doi: <pub-id pub-id-type="doi">10.1128/AAC.00030-11</pub-id>
</citation>
</ref>
<ref id="B31">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rath</surname> <given-names>K. S.</given-names>
</name>
<name>
<surname>Naidu</surname> <given-names>S. K.</given-names>
</name>
<name>
<surname>Lata</surname> <given-names>P.</given-names>
</name>
<name>
<surname>Bid</surname> <given-names>H. K.</given-names>
</name>
<name>
<surname>Rivera</surname> <given-names>B. K.</given-names>
</name>
<name>
<surname>McCann</surname> <given-names>G. A.</given-names>
</name>
</person-group> (<year>2014</year>). <article-title>HO-3867, a Safe STAT3 Inhibitor, is Selectively Cytotoxic to Ovarian Cancer</article-title>. <source>Cancer Res.</source> <volume>74</volume>, <fpage>2316</fpage>&#x2013;<lpage>2327</lpage>. doi: <pub-id pub-id-type="doi">10.1158/0008-5472.CAN-13-2433</pub-id>
</citation>
</ref>
<ref id="B32">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Reers</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Smiley</surname> <given-names>S. T.</given-names>
</name>
<name>
<surname>Mottola-Hartshorn</surname> <given-names>C.</given-names>
</name>
<name>
<surname>Chen</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Lin</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Chen</surname> <given-names>L. B.</given-names>
</name>
</person-group> (<year>1995</year>). <article-title>Mitochondrial Membrane Potential Monitored by JC-1 Dye</article-title>. <source>Methods Enzymol.</source> <volume>260</volume>, <fpage>406</fpage>&#x2013;<lpage>417</lpage>. doi: <pub-id pub-id-type="doi">10.1016/0076-6879(95)60154-6</pub-id>
</citation>
</ref>
<ref id="B33">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rosa</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Murgia</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Putzu</surname> <given-names>D.</given-names>
</name>
<name>
<surname>Meli</surname> <given-names>V.</given-names>
</name>
<name>
<surname>Falchi</surname> <given-names>A. M.</given-names>
</name>
</person-group> (<year>2015</year>). <article-title>Monoolein-Based Cubosomes Affect Lipid Profile in HeLa Cells</article-title>. <source>Chem. Phys. Lipids</source> <volume>191</volume>, <fpage>96</fpage>&#x2013;<lpage>105</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.chemphyslip.2015.08.017</pub-id>
</citation>
</ref>
<ref id="B34">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Schmittgen</surname> <given-names>T. D.</given-names>
</name>
<name>
<surname>Livak</surname> <given-names>K. J.</given-names>
</name>
</person-group> (<year>2008</year>). <article-title>Analyzing Real-Time PCR Data by the Comparative C(T) Method</article-title>. <source>Nat. Protoc.</source> <volume>3</volume>, <fpage>1101</fpage>&#x2013;<lpage>1108</lpage>. doi: <pub-id pub-id-type="doi">10.1038/nprot.2008.73</pub-id>
</citation>
</ref>
<ref id="B35">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Selvendiran</surname> <given-names>K.</given-names>
</name>
<name>
<surname>Ahmed</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Dayton</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Kuppusamy</surname> <given-names>M. L.</given-names>
</name>
<name>
<surname>Tazi</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Bratasz</surname> <given-names>A.</given-names>
</name>
<etal/>
</person-group>. (<year>2010</year>). <article-title>Safe and Targeted Anticancer Efficacy of a Novel Class of Antioxidant-Conjugated Difluorodiarylidenyl Piperidones: Differential Cytotoxicity in Healthy and Cancer Cells</article-title>. <source>Free Radic. Biol. Med.</source> <volume>48</volume>, <fpage>1228 </fpage>&#x2013;<lpage>12 35</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.freeradbiomed.2010.02.009</pub-id>
</citation>
</ref>
<ref id="B36">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sengupta</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Chowdhury</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Bosedasgupta</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Wright</surname> <given-names>C. W.</given-names>
</name>
<name>
<surname>Majumder</surname> <given-names>H. K.</given-names>
</name>
</person-group> (<year>2011</year>). <article-title>Cryptolepine-Induced Cell Death of <italic>Leishmania Donovani</italic> Promastigotes Is Augmented by Inhibition of Autophagy</article-title>. <source>Mol. Biol. Int.</source> <volume>2011</volume>, <fpage>187850</fpage>. doi: <pub-id pub-id-type="doi">10.4061/2011/187850</pub-id>
</citation>
</ref>
<ref id="B37">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sercombe</surname> <given-names>L.</given-names>
</name>
<name>
<surname>Veerati</surname> <given-names>T.</given-names>
</name>
<name>
<surname>Moheimani</surname> <given-names>F.</given-names>
</name>
<name>
<surname>Wu</surname> <given-names>S. Y.</given-names>
</name>
<name>
<surname>Sood</surname> <given-names>A. K.</given-names>
</name>
<name>
<surname>Hua</surname> <given-names>S.</given-names>
</name>
</person-group> (<year>2015</year>). <article-title>Advances and Challenges of Liposome Assisted Drug Delivery</article-title>. <source>Front. Pharmacol.</source> <volume>6</volume>, <elocation-id>286</elocation-id>. doi: <pub-id pub-id-type="doi">10.3389/fphar.2015.00286</pub-id>
</citation>
</ref>
<ref id="B38">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shadab</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Jha</surname> <given-names>B.</given-names>
</name>
<name>
<surname>Asad</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Deepthi</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Kamran</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Ali</surname> <given-names>N.</given-names>
</name>
</person-group> (<year>2017</year>). <article-title>Apoptosis-Like Cell Death in <italic>Leishmania Donovani</italic> Treated With KalsomeTM10, a New Liposomal Amphotericin B</article-title>. <source>PloS One</source> <volume>12</volume>, <fpage>e0171306</fpage>. doi: <pub-id pub-id-type="doi">10.1371/journal.pone.0171306</pub-id>
</citation>
</ref>
<ref id="B39">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Singh</surname> <given-names>O. P.</given-names>
</name>
<name>
<surname>Singh</surname> <given-names>B.</given-names>
</name>
<name>
<surname>Chakravarty</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Sundar</surname> <given-names>S.</given-names>
</name>
</person-group> (<year>2016</year>). <article-title>Current Challenges in Treatment Options for Visceral Leishmaniasis in India: A Public Health Perspective</article-title>. <source>Infect. Dis. Poverty</source> <volume>5</volume>, <fpage>19</fpage>. doi: <pub-id pub-id-type="doi">10.1186/s40249-016-0112-2</pub-id>
</citation>
</ref>
<ref id="B40">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sinjari</surname> <given-names>B.</given-names>
</name>
<name>
<surname>Pizzicannella</surname> <given-names>J.</given-names>
</name>
<name>
<surname>D'Aurora</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Zappacosta</surname> <given-names>R.</given-names>
</name>
<name>
<surname>Gatta</surname> <given-names>V.</given-names>
</name>
<name>
<surname>Fontana</surname> <given-names>A.</given-names>
</name>
<etal/>
</person-group>. (<year>2019</year>). <article-title>Curcumin/Liposome Nanotechnology as Delivery Platform for Anti-Inflammatory Activities <italic>via</italic> NFkB/ERK/pERK Pathway in Human Dental Pulp Treated With 2-HydroxyEthyl MethAcrylate (HEMA)</article-title>. <source>Front. Physiol.</source> <volume>10</volume>, <elocation-id>633</elocation-id>. doi: <pub-id pub-id-type="doi">10.3389/fphys.2019.00633</pub-id>
</citation>
</ref>
<ref id="B41">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sivandzade</surname> <given-names>F.</given-names>
</name>
<name>
<surname>Bhalerao</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Cucullo</surname> <given-names>L.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>Analysis of the Mitochondrial Membrane Potential Using the Cationic JC-1 Dye as a Sensitive Fluorescent Probe</article-title>. <source>Bio Protoc.</source> <volume>9</volume>, <fpage>e3128</fpage>. doi: <pub-id pub-id-type="doi">10.21769/BioProtoc.3128</pub-id>
</citation>
</ref>
<ref id="B42">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tierney</surname> <given-names>B. J.</given-names>
</name>
<name>
<surname>McCann</surname> <given-names>G. A.</given-names>
</name>
<name>
<surname>Cohn</surname> <given-names>D. E.</given-names>
</name>
<name>
<surname>Eisenhauer</surname> <given-names>E.</given-names>
</name>
<name>
<surname>Sudhakar</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Kuppusamy</surname> <given-names>P.</given-names>
</name>
<etal/>
</person-group>. (<year>2012</year>). <article-title>HO-3867, a STAT3 Inhibitor Induces Apoptosis by Inactivation of STAT3 Activity in BRCA1-Mutated Ovarian Cancer Cells</article-title>. <source>Cancer Biol. Ther.</source> <volume>13</volume>, <fpage>766</fpage>&#x2013;<lpage>775</lpage>. doi: <pub-id pub-id-type="doi">10.4161/cbt.20559</pub-id>
</citation>
</ref>
<ref id="B43">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tomiotto-Pellissier</surname> <given-names>F.</given-names>
</name>
<name>
<surname>Bortoleti</surname> <given-names>B.</given-names>
</name>
<name>
<surname>Assolini</surname> <given-names>J. P.</given-names>
</name>
<name>
<surname>Gon&#xe7;alves</surname> <given-names>M. D.</given-names>
</name>
<name>
<surname>Carloto</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Miranda-Sapla</surname> <given-names>M. M.</given-names>
</name>
<etal/>
</person-group>. (<year>2018</year>). <article-title>Macrophage Polarization in Leishmaniasis: Broadening Horizons</article-title>. <source>Front. Immunol.</source> <volume>9</volume>, <elocation-id>2529</elocation-id>. doi: <pub-id pub-id-type="doi">10.3389/fimmu.2018.02529</pub-id>
</citation>
</ref>
<ref id="B44">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wanderley</surname> <given-names>J. L. M.</given-names>
</name>
<name>
<surname>DaMatta</surname> <given-names>R. A.</given-names>
</name>
<name>
<surname>Barcinski</surname> <given-names>M. A.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>Apoptotic Mimicry as a Strategy for the Establishment of Parasitic Infections: Parasite- and Host-Derived Phosphatidylserine as Key Molecule</article-title>. <source>Cell Commun. Signal</source> <volume>18</volume>, <fpage>10</fpage>. doi: <pub-id pub-id-type="doi">10.1186/s12964-019-0482-8</pub-id>
</citation>
</ref>
<ref id="B45">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Weing&#xe4;rtner</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Kemmer</surname> <given-names>G.</given-names>
</name>
<name>
<surname>M&#xfc;ller</surname> <given-names>F. D.</given-names>
</name>
<name>
<surname>Zampieri</surname> <given-names>R. A.</given-names>
</name>
<name>
<surname>Gonzaga dos Santos</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Schiller</surname> <given-names>J.</given-names>
</name>
<etal/>
</person-group>. (<year>2012</year>). <article-title>
<italic>Leishmania</italic> Promastigotes Lack Phosphatidylserine But Bind Annexin V Upon Permeabilization or Miltefosine Treatment</article-title>. <source>PloS One</source> <volume>7</volume>, <fpage>e42070</fpage>. doi: <pub-id pub-id-type="doi">10.1371/journal.pone.0042070</pub-id>
</citation>
</ref>
<ref id="B46">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhao</surname> <given-names>K.</given-names>
</name>
<name>
<surname>Zhao</surname> <given-names>G. M.</given-names>
</name>
<name>
<surname>Wu</surname> <given-names>D.</given-names>
</name>
<name>
<surname>Soong</surname> <given-names>Y.</given-names>
</name>
<name>
<surname>Birk</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Schiller</surname> <given-names>V.</given-names>
</name>
<etal/>
</person-group>. (<year>2004</year>). <article-title>Cell-Permeable Peptide Antioxidants Targeted to Innermitochondrial Membrane Inhibit Mitochondrial Swelling, Oxidative Cell Death, and Reperfusioninjury</article-title>. <source>J. Biol. Chem.</source> <volume>279</volume>, <fpage>34682</fpage>&#x2013;<lpage>34690</lpage>. doi: <pub-id pub-id-type="doi">10.1074/jbc.M402999200</pub-id>
</citation>
</ref>
</ref-list>
</back>
</article>